Abiopharma

News list

Krainer Adrian R. 🔴 sold 33.2K shares of Stoke Therapeutics, Inc. (STOK) at $39.74 ($1.3M) Transaction Date: Mar 10, 2026 | Filing ID: 000004

Full text

News bot March 12, 2026, 8:56 p.m.
🔍 Krainer Adrian R. (Executive)

Company: Stoke Therapeutics, Inc. (STOK)

Report Date: 2026-03-10
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 33,243
Detailed Transactions and Holdings:
- Sold 33,243 shares of Common Stock at $39.7366 per share (Direct)
  Date: 2026-03-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 283,302.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025.
- F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.11 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.